Doctor profile · Federal record
Dr. Kevin Liebmann
Nurse Practitioner · Nurse Practitioner · Princeton, NJ
- NPI 1154939064
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 6 yrs in practice
- Licensed in 2 states
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
208 Bunn Dr
Princeton, NJ 085402851
(609) 683-4999 - Mailing address
-
208 Bunn Drive
Princeton, NJ 085406493
Credentials & registration
- NPI registered
- July 2020 — 6 yrs on file
- Profile last updated
- January 9, 2022
- Year of graduation
- 2020 — 6 yrs since
- Specialty taxonomy
- 363L00000X — NUCC code
- State licenses (2)
- New Jersey #26NJ01046900 · New York #346148
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1154939064. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
3,542
Distinct HCPCS
10
Medicare allowed
$199,234
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,295 | 222 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 665 | 444 | $83 | |
17000 |
Destruction of precancer skin growth, 1 growth | 427 | 294 | $44 | |
11102 |
Biopsy of related skin growth, first growth | 333 | 267 | $84 | |
17110 |
Destruction of skin growth, 1-14 growths | 182 | 138 | $107 | |
11103 |
Biopsy of related skin growth, each additional growth | 165 | 97 | $48 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 124 | 96 | $118 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 70 | 53 | $161 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 57 | 49 | $53 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 54 | 54 | $104 |
In context: peer comparison
Among 4 peers in Princeton Nurse Practitioner, average services per provider: 147. This provider delivers 24× the peer median.Open Payments
Industry payments received
All-time total
$406
Transactions
23
Manufacturers
13
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Incyte Corporation | 5 | $89.89 | |
| Regeneron Healthcare Solutions, INC. | 3 | $52.14 | |
| Mayne Pharma Commercial LLC | 2 | $42.00 | |
| Galderma Laboratories, L.P. | 2 | $37.12 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $36.03 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | 2 | $31.46 | |
| Lilly USA, LLC | 1 | $18.48 | |
| Leo Pharma INC. | 1 | $17.71 | |
| Janssen Biotech, INC. | 1 | $17.60 | |
| Pfizer INC. | 1 | $16.89 | |
| Arcutis Biotherapeutics, INC. | 1 | $16.15 | |
| Verrica Pharmaceuticals INC. | 1 | $16.08 | |
| Dermavant Sciences, INC. | 1 | $14.31 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
671
Patients
527
Total drug cost
$16,133
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 145 | 115 | $1,162 |
| Mupirocin | Generic | 141 | 128 | $986 |
| Ketoconazole | Generic | 101 | 63 | $2,080 |
| Hydrocortisone | Generic | 55 | 53 | $307 |
| Clobetasol Propionate | Generic | 53 | 37 | $2,297 |
| Fluorouracil | Generic | 36 | 33 | $2,934 |
| Doxycycline Hyclate | Generic | 33 | 31 | $1,110 |
| Metronidazole | Generic | 33 | 23 | $1,349 |
| Nystatin | Generic | 25 | 17 | $307 |
| Minoxidil | Generic | 17 | 0 | $507 |
Frequently asked questions
What is Dr. Kevin Liebmann's medical specialty?
Dr. Kevin Liebmann practices Nurse Practitioner in Princeton, NJ.
Where does Dr. Kevin Liebmann practice?
Dr. Kevin Liebmann practices at 208 Bunn Dr, Princeton, NJ 085402851. Office phone: 6096834999.
What is Dr. Kevin Liebmann's NPI?
Dr. Kevin Liebmann's National Provider Identifier (NPI) is 1154939064, issued by NPPES.
Does Dr. Kevin Liebmann accept Medicare assignment?
Yes. Dr. Kevin Liebmann accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Kevin Liebmann commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.